What move does the options market price into Elanco Animal Health's report?

Implied ±7.7%, either direction.

ELANNYSEPharmaceutical Preparations

Elanco Animal Health Inc (ELAN) earnings date, market-implied expected move, and options open interest by expiry

23.06

−0.18 · −0.77%

post 23.06 0.00%

Closed16:00 ET

Open23.19Volume3.5MMkt cap$11.5BEPS-0.41

Day22.93 – 23.3829%52-wk19.40 – 27.9843%

ELAN

Elanco Animal Health Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±7.7%implied · report alone

21.2924.83

straddle ±9.7%

spot 23.06exp Nov 20ATM strike 23ATM straddle 2.63IV 60%

Oct 30 closereport share · term structure

Expected move

Inputs

Next report

Nov 6

before open · in 4 days

confirmedQ3 FY26

Calendar

Next report

Last report

+2.42%

shaded = implied · ▲▼ = realized

Aug 5 '26 · confirmed

Implied vs realized

Linked news

87dTARS · customerTarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth

News

Largest filed tie

13F top-10 QoQ

+0.36%

shares held · 10 largest managers

13F · Jun 30 '26125d lag

525 managers

Top fund weight

0.34%

ELAN weight · MDY

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Elanco Animal Health (ELAN) reports on Nov 6 before open (confirmed date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 5 '26confirmed—▲+2.42%—

quarterimplied−5%0+5%realized×

Q2 FY26—▲+2.42%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 30 close

0.34OI · 4 expiries · Oct 30 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

148+1%

Positioning

Linked exposure

scenario · straddle±9.7%

Funds 3

MDY±0.0%

VTI±0.0%

VT±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

3.95%as filednet margin · revenue −0.22% QoQ · +10.23% YoY

Revenue

$1.4B−0.22% QoQ

Gross profit

$798M+1.66% QoQ

58.33% margin

Operating income

$115M−20.14% QoQ

8.41% margin

Pre-tax income

$56M−35.63% QoQ

Net income

$54M−5.26% QoQ

3.95% margin

Cost of revenue

$570M−2.73% QoQ

Operating expenses

$683M+6.55% QoQ

SG&A $449M

R&D $92M

Other operating $142M

Other expense

$59M

Tax

$2M−93.33% QoQ

Revenue$1.4B−0.22%

Gross profit

$798M+1.66%

58.33% margin

Operating income

$115M−20.14%

8.41% margin

Pre-tax income

$56M−35.63%

Net income

$54M−5.26%

3.95% margin

Cost of revenue

$570M−2.73%

Operating expenses

$683M+6.55%

SG&A $449M

R&D $92M

Other operating $142M

Other expense

$59M

Tax$2M−93.33%

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Oct 30 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.99· ±3.8% vs ±1.9% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±3.8%11 of 24×1.99

NFPjobs report±2.8%6 of 10×1.46

CPIconsumer prices±2.0%5 of 10×1.05

PCEpersonal income & outlays±1.7%8 of 19×0.89

PPIproducer prices±1.5%5 of 10×0.81

GDPgross domestic product±1.5%11 of 19×0.78

CPROFcorporate profits±1.3%7 of 12×0.70

Bar = avg |move| to ±4% · tick = ±1.9% avg day · ×base = |move| ÷ ±1.9% · min 6 releases

Earnings history

EPS 0.11 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 5 '26 · confirmed	0.11	—
Q1 FY26	—	0.11	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod